ODE Chief Tillman Defends 510(k) Program At Minnesota Industry Meeting
This article was originally published in The Gray Sheet
Executive Summary
FDA's head of device evaluation is defending the agency's handling of 510(k) pre-market notification submissions in the face of criticism from two groups: those who charge the agency has allowed devices on the market without sufficient scientific evidence, and industry representatives who claim that FDA often demands too much from 510(k) applicants
You may also be interested in...
Device Center Discord: 510(k) Review Process Is Flash Point At CDRH
Details trickling into the public sphere about CDRH's device review process reveal heightened tension between reviewers and management over the proper response to a 510(k) submission
Device Center Discord: 510(k) Review Process Is Flash Point At CDRH
Details trickling into the public sphere about CDRH's device review process reveal heightened tension between reviewers and management over the proper response to a 510(k) submission
FDA Needs More Resources, Good Leadership, Daschle Tells Senate Panel
At a Jan. 8 confirmation hearing before the Senate Health, Education, Labor and Pensions Committee, HHS Secretary nominee Tom Daschle said that FDA needs more resources, better public policy and stronger leadership if it is to improve the device and drug approval processes and worker morale